| Filed On | Filing |
|---|---|
| 13 May 2025 |
Form 4/A: Graham G. Walmsley, Director
Holds 1,800,000 shares of Common Stock |
| 18 Dec 2024 |
Form 4/A: Graham G. Walmsley, Director
Sold 700,761 shares ($4.73M) · Bought 700,761 shares ($4.73M) |
| 26 Nov 2024 |
Form 4/A: Graham G. Walmsley, Director
Sold 1,175,000 shares ($17.4M) |
| 05 Sep 2023 |
Form 4/A: Harmon Cyrus, Director
Sold 15,000 shares ($152K) |
| 23 Sep 2022 |
Form 4/A: Bohen Sean, Director
Bought 20,000 shares |
| 27 Jun 2022 |
Form 4/A: Larson Yi, Director
Granted 21,520 Stock Option (Right to Buy) |
| 27 Jun 2022 |
Form 4/A: Horning Sandra, Director
Granted 21,520 Stock Option (right to buy) |
| 27 Jun 2022 |
Form 4/A: Clark Ian T, Director
Granted 21,520 Stock Option (right to buy) |
| 27 Jun 2022 |
Form 4/A: Butitta Cynthia M, Director
Granted 21,520 Stock Option (right to buy) |
| 27 Jun 2022 |
Form 4/A: Graham G. Walmsley, Director
Granted 21,520 Stock Option (right to buy) |
| 27 Jun 2022 |
Form 4/A: Hrustanovic Gorjan, Director
Granted 21,520 Stock Option (right to buy) |
| 27 Jun 2022 |
Form 4/A: Rappaport Andrew, Director
Granted 21,520 Stock Option (right to buy) |
| 20 Nov 2020 |
Form 4/A: Graham G. Walmsley, Director
Acquired 339,578 Series B Convertible Preferred Stock (Open Market Purchase) ($1.6M) |
| 20 Nov 2020 |
Form 4/A: Harmon Cyrus, Director
Granted 1,076 Stock Option (Right to Buy) |
Loading...